Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Critical Care (London, England)|February 27, 2008
Clinical trials in severe sepsis with drotrecogin alfa (activated)Pierre-François LaterreCurrent Opinion in Infectious Diseases|July 3, 2008
Progress in medical management of intra-abdominal infectionPierre-François LaterreExpert Review of Gastroenterology & Hepatology|December 21, 2017
Hepatorenal syndrome: the clinical impact of vasoactive therapyIsabelle Colle, Pierre-François LaterreCritical Care (London, England)|November 20, 2003
Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis--practical aspects at the bedside and patient identificationPierre-François Laterre, Xavier WitteboleAmerican Journal of Surgery|January 11, 2003
Management of patients with severe sepsis, treated by drotrecogin alfa (activated)Pierre-François Laterre, Darell HeiselmanBMC Gastroenterology|September 29, 2014
Tracking the foreign body, a rare cause of hepatic abscessCarole Dangoisse, Pierre-François LaterreEuropean Radiology|April 27, 2002
Traumatic injuries: imaging and intervention in post-traumatic complications (delayed intervention)Pierre P Goffette, Pierre-François LaterreClinical Case Reports|March 19, 2020
Leptospirosis-induced purpura: An atypical manifestation of Weil's diseaseJulien Higny, Frédéric Forêt, Pierre-François LaterreThe Journal of Infectious Diseases|January 29, 2003
Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infectionsLaurent Blairon, Xavier Wittebole, Pierre-François LaterreCurrent Opinion in Anaesthesiology|December 8, 2022
Preoperative frailty screening, assessment and managementMaximilien Cappe, Pierre-François Laterre, Mélanie DechampsPageof 16